Omeros CorpOMER
Price$18.47

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $9.9MTTM through 30 Jun 2026
Net Income $124.8MTTM through 30 Jun 2026
Free Cash Flow -$68.7MTTM through 30 Jun 2026

Margins

Current
Gross Margin94.1%
EBITDA Margin-726.9%
Operating Margin-176.0%
Net Margin566.7%

Returns

-219.8%ROE
48.6%ROA

Balance Sheet Health

Debt / Equity-1.12x
Current Ratio2.28x
Net Debt-$64.5Mnet cash position
Cash & Equivalents$2M

Quality Metrics

Altman Z-Score-1.84
Piotroski F-Score3 / 9
FCF Margin-694.7%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'17'18'19'20
FY2020: $73.8M
Diluted EPS$1.73TTM
'19'20'21'22'23'24'25
FY2025: $-0.05

Dividend

No dividend

Capital Allocation

Capex Intensity0.6%

Segment Performance

SegmentRevenueYoYOutlook
YARTEMLEA Product Sales$9.9M
View details

Launched in January 2026 in the U.S. market. Simplification of billing expected with permanent J-code effective July 1, 2026.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.